Quarterly report pursuant to sections 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 32 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Costs and expenses:      
Research and development $ 1,073,781 $ 49,586 $ 2,915,296
General and administrative 1,055,247 62,547 3,043,762
Total costs and expenses 2,129,027 112,133 5,959,058
Loss from operations (2,129,027) (112,133) (5,959,058)
Other expense, net 9,996 0 10,684
Net loss $ (2,139,024) $ (112,133) $ (5,969,742)
Net loss per share - basic and diluted (in dollars per share) $ (0.07) $ (0.01)  
Weighted average common shares outstanding:      
Basic and diluted (in shares) 32,000,000 10,000,000